Bastatas, Francis .
HRN: 25-90-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/19/2025
05/25/2025
IV
500 Mg
OD
Sepsis, Bloodstream Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes